For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241003:nRSC8869Ga&default-theme=true
RNS Number : 8869G Polar Capital Global Health Tst PLC 03 October 2024
3(rd) October 2024
Polar Capital Global Healthcare Trust plc (the "Company")
Top Ten Equity Holdings and Sector and Geographic Exposure as at 30(th)
September 2024 full Portfolio listing as at 30(th) August 2024 available from
company's website.
Polar Capital Global Healthcare Trust plc is pleased to announce that as at
30(th) September 2024 the top ten equity holdings and the sector and
geographic breakdown were as follows:
Top 10 Holdings %
Eli Lilly & Co 7.9%
UnitedHealth Group 7.7%
Novo Nordisk A/S 6.1%
AbbVie 4.7%
Roche 4.5%
Sanofi 3.6%
Fresenius SE & Co KGaA 3.3%
Sandoz Group AG 3.1%
Terumo Corp 3.1%
Intuitive Surgical 3.0%
Total 46.9%
Sector Exposure %
Pharmaceuticals 28.0%
Biotechnology 20.5%
Healthcare Equipment 14.4%
Life Sciences Tools & Services 10.8%
Managed Healthcare 7.7%
Healthcare Supplies 5.3%
Healthcare Facilities 3.5%
Healthcare Services 3.3%
Metal, Glass & Plastic Containers 2.3%
Healthcare Technology 2.3%
Healthcare Distributors 0.9%
Cash 1.0%
Total 100.0%
Geographic Exposure %
United States 46.3%
Switzerland 12.6%
Denmark 8.7%
Japan 6.1%
France 6.0%
Netherlands 3.9%
Ireland 3.5%
Germany 3.3%
Belgium 2.8%
United Kingdom 2.4%
Sweden 2.1%
Italy 1.4%
Cash 1.0%
Total 100.0%
The monthly factsheet will usually be available on the Company's website on
the 10(th) working day after the month end and includes a commentary by the
investment manager. www.Polarcapitalhealthcaretrust.co
(http://www.Polarcapitalhealthcaretrust.com) m
(http://www.Polarcapitalhealthcaretrust.com)
Neither the contents of the Company's website nor the contents of any website
accessible from the hyperlinks on the Company's website (or any other website)
is incorporated into or forms part of this announcement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END PFUDZMGGKFKGDZM
Recent news on Polar Capital Global Healthcare Trust